BARISUR STUDY: DESCRIPTIVE STUDY OF BARICITINIB SAFETY IN SPANISH PATIENTS WITH RHEUMATOID ARTHRITIS

被引:0
|
作者
Rubio Romero, E. [1 ]
Gallego, A. [2 ]
Llanes, M. [3 ]
Delgado Vidal, E. [4 ]
机构
[1] Seville Hosp Univ Virgen Rocio, Rheumatol, Seville, Spain
[2] Hosp Univ Badajoz, Rheumatol, Badajoz, Spain
[3] Hosp Univ Juan Ramon Jimenez, Rheumatol, Huelva, Spain
[4] Rheumatol, Seville, Spain
关键词
Safety; Rheumatoid arthritis; Descriptive studies;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
POS0863
引用
收藏
页码:736 / 736
页数:1
相关论文
共 50 条
  • [31] Infections in baricitinib clinical trials for patients with active rheumatoid arthritis
    Winthrop, Kevin L.
    Harigai, Masayoshi
    Genovese, Mark C.
    Lindsey, Stephen
    Takeuchi, Tsutomu
    Fleischmann, Roy
    Bradley, John D.
    Byers, Nicole L.
    Hyslop, David L.
    Issa, Maher
    Nishikawa, Atsushi
    Rooney, Terence P.
    Witt, Sarah
    Dickson, Christina L.
    Smolen, Josef S.
    Dougados, Maxime
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (10) : 1290 - 1297
  • [32] Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study
    Cassone, Giulia
    Manfredi, Andreina
    Atzeni, Fabiola
    Venerito, Vincenzo
    Vacchi, Caterina
    Picerno, Valentina
    Furini, Federica
    Erre, Gian Luca
    Tomietto, Paola
    Fedele, Anna Laura
    Della Casa, Giovanni
    Nucera, Valeria
    Giannitti, Chiara
    Salvarani, Carlo
    Sebastiani, Marco
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (01)
  • [33] Tofacitinib and Baricitinib in Type 2 Diabetic Patients with Rheumatoid Arthritis
    Martinez-Molina, Cristina
    Diaz-Torne, Cesar
    Park, Hye S.
    Feliu, Anna
    Vidal, Silvia
    Corominas, Hector
    MEDICINA-LITHUANIA, 2024, 60 (03):
  • [34] Efficacy of baricitinib in patients with moderate-to-severe rheumatoid arthritis with 3 years of treatment: results from a long-term study
    Smolen, Josef S.
    Xie, Li
    Jia, Bochao
    Taylor, Peter C.
    Burmester, Gerd
    Tanaka, Yoshiya
    Elias, Ayesha
    Cardoso, Anabela
    Ortmann, Rob
    Walls, Chad
    Dougados, Maxime
    RHEUMATOLOGY, 2021, 60 (05) : 2256 - 2266
  • [35] Efficacy of baricitinib in patients with moderate-to-severe rheumatoid arthritis up to 6.5 years of treatment: results of a long-term study
    Caporali, Roberto
    Taylor, Peter C.
    Aletaha, Daniel
    Sanmarti, Raimon
    Takeuchi, Tsutomu
    Mo, Daojun
    Haladyj, Ewa
    Bello, Natalia
    Zaremba-Pechmann, Liliana
    Fang, Ying
    Dougados, Maxime
    RHEUMATOLOGY, 2024, 63 (10) : 2799 - 2809
  • [36] Safety of baricitinib in East Asian patients with moderate-to-severe active rheumatoid arthritis: An integrated analysis from clinical trials
    Chen, Ying-Chou
    Yoo, Dae Hyun
    Lee, Chang Keun
    Li, Ko-Jen
    Won, Ji-Eon
    Wu, Wen-Shuo
    Zhong, Jinglin
    Nicolay, Claudia
    Walls, Chad Daniel
    Tanaka, Yoshiya
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2020, 23 (01) : 65 - 73
  • [37] Relative efficacy and safety of tofacitinib, baricitinib, upadacitinib, and filgotinib in comparison to adalimumab in patients with active rheumatoid arthritis
    Lee, Young Ho
    Song, Gwan Gyu
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2020, 79 (08): : 785 - 796
  • [38] Addressing the safety of anakinra in patients with rheumatoid arthritis
    Fleischmann, RM
    RHEUMATOLOGY, 2003, 42 : 29 - 35
  • [39] Efficacy and safety of switching Jak inhibitors in rheumatoid arthritis: an observational study
    Retuerto, M.
    Trujillo, E.
    Valero, C.
    Fernandez-Espartero, C.
    Soleto, C. Y.
    Garcia-Valle, A.
    Aurrecoechea, E.
    Garijo, M.
    Lopez, A.
    Loricera, J.
    Pablos, J. L.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (03) : 453 - 455
  • [40] Profile of Patients with Rheumatoid Arthritis: a Descriptive Analysis
    de Oliveira, Junior Garcia
    Garabeli, Aline Ansbach
    Daher, Joselia Borba
    BRAZILIAN ARCHIVES OF BIOLOGY AND TECHNOLOGY, 2022, 65